301301.SZ
Yili Chuannig Biotechnology Co., Ltd.
SZSE · C 制造业 · CN
CNY 7.21
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 4.4B | 4.6B | 5.8B | 4.8B | 3.8B |
| Cost of Revenue | 3.3B | 3.3B | 3.7B | 3.3B | 2.9B |
| Gross Profit | 1.1B | 1.4B | 2.1B | 1.5B | 947.4M |
| Operating Expenses | |||||
| R&D Expense | 84.5M | 102.5M | 77.7M | 55.3M | 35.4M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 148.8M | 152.0M | 165.3M | 143.1M | 144.1M |
| Selling & Marketing Expense | 31.0M | 29.2M | 25.5M | 22.6M | 11.5M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 363.4M | 381.4M | 396.7M | 348.4M | 368.9M |
| Cost and Expenses | 3.7B | 3.6B | 4.1B | 3.6B | 3.2B |
| Operating Income (EBIT) | 746.1M | 957.0M | 1.7B | 1.1B | 545.1M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 727.4M | 938.7M | 1.7B | 1.1B | 487.6M |
| Income Tax Expense | 137.2M | 170.3M | 274.7M | 177.1M | 76.1M |
| Bottom Line | |||||
| Net Income | 591.5M | 769.0M | 1.4B | 940.6M | 411.5M |
| Earnings from Cont. Ops | 590.2M | 768.3M | 1.4B | 940.6M | 411.5M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 591.5M | 769.0M | 1.4B | 940.6M | 411.5M |
| Per Share | |||||
| Basic EPS | CN¥0.26 | CN¥0.34 | CN¥0.63 | CN¥0.42 | CN¥0.21 |
| Diluted EPS | CN¥0.26 | CN¥0.34 | CN¥0.63 | CN¥0.42 | CN¥0.21 |
| Revenue Per Share | CN¥1.99 | CN¥2.04 | CN¥2.59 | CN¥2.15 | CN¥1.95 |
| Shares | |||||
| Basic Shares Outstanding | 2.2B | 2.3B | 2.2B | 2.2B | 2.0B |
| Diluted Shares Outstanding | 2.2B | 2.3B | 2.2B | 2.2B | 2.0B |
| Profitability Metrics | |||||
| EBITDA | — | 1.5B | 2.2B | 1.7B | 1.1B |
| D&A | — | 573.4M | 542.6M | 544.6M | 547.4M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026